178 related articles for article (PubMed ID: 2920211)
1. A point mutation in the coding region of uroporphyrinogen decarboxylase associated with familial porphyria cutanea tarda.
Garey JR; Hansen JL; Harrison LM; Kennedy JB; Kushner JP
Blood; 1989 Mar; 73(4):892-5. PubMed ID: 2920211
[TBL] [Abstract][Full Text] [Related]
2. Steady-state levels of uroporphyrinogen decarboxylase mRNA in lymphoblastoid cell lines from patients with familial porphyria cutanea tarda and their relatives.
Hansen JL; Pryor MA; Kennedy JB; Kushner JP
Am J Hum Genet; 1988 Jun; 42(6):847-53. PubMed ID: 3369447
[TBL] [Abstract][Full Text] [Related]
3. Familial porphyria cutanea tarda: hybridization analysis of the uroporphyrinogen decarboxylase locus.
Hansen JL; O'Connell P; Romana M; Romeo PH; Kushner JP
Hum Hered; 1988; 38(5):283-6. PubMed ID: 2906904
[TBL] [Abstract][Full Text] [Related]
4. Uroporphyrinogen decarboxylase: a splice site mutation causes the deletion of exon 6 in multiple families with porphyria cutanea tarda.
Garey JR; Harrison LM; Franklin KF; Metcalf KM; Radisky ES; Kushner JP
J Clin Invest; 1990 Nov; 86(5):1416-22. PubMed ID: 2243121
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of familial porphyria cutanea tarda.
Roberts AG; Elder GH; Newcombe RG; Enriquez de Salamanca R; Munoz JJ
J Med Genet; 1988 Oct; 25(10):669-76. PubMed ID: 3225822
[TBL] [Abstract][Full Text] [Related]
6. Immunoreactive uroporphyrinogen decarboxylase in porphyria cutanea tarda.
Elder GH; Sheppard DM; Tovey JA; Urquhart AJ
Lancet; 1983 Jun; 1(8337):1301-4. PubMed ID: 6134095
[TBL] [Abstract][Full Text] [Related]
7. Identification of a new mutation responsible for hepatoerythropoietic porphyria.
Romana M; Grandchamp B; Dubart A; Amselem S; Chabret C; Nordmann Y; Goossens M; Romeo PH
Eur J Clin Invest; 1991 Apr; 21(2):225-9. PubMed ID: 1905636
[TBL] [Abstract][Full Text] [Related]
8. Functional consequences of naturally occurring mutations in human uroporphyrinogen decarboxylase.
Phillips JD; Parker TL; Schubert HL; Whitby FG; Hill CP; Kushner JP
Blood; 2001 Dec; 98(12):3179-85. PubMed ID: 11719352
[TBL] [Abstract][Full Text] [Related]
9. Enzymatic and immunological studies of uroporphyrinogen decarboxylase in familial porphyria cutanea tarda and hepatoerythropoietic porphyria.
de Verneuil H; Beaumont C; Deybach JC; Nordmann Y; Sfar Z; Kastally R
Am J Hum Genet; 1984 May; 36(3):613-22. PubMed ID: 6375356
[TBL] [Abstract][Full Text] [Related]
10. Uroporphyrinogen decarboxylase structural mutant (Gly281----Glu) in a case of porphyria.
de Verneuil H; Grandchamp B; Beaumont C; Picat C; Nordmann Y
Science; 1986 Nov; 234(4777):732-4. PubMed ID: 3775362
[TBL] [Abstract][Full Text] [Related]
11. Genetics and pathogenesis of human uroporphyrinogen decarboxylase defects.
Elder GH; Roberts AG; de Salamanca RE
Clin Biochem; 1989 Jun; 22(3):163-8. PubMed ID: 2786774
[TBL] [Abstract][Full Text] [Related]
12. Analysis of uroporphyrinogen decarboxylase complementary DNAs in sporadic porphyria cutanea tarda.
Garey JR; Franklin KF; Brown DA; Harrison LM; Metcalf KM; Kushner JP
Gastroenterology; 1993 Jul; 105(1):165-9. PubMed ID: 8099886
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of uroporphyrinogen decarboxylase deficiency in a family with two cases of hepatoerythropoietic porphyria.
de Verneuil H; Grandchamp B; Romeo PH; Raich N; Beaumont C; Goossens M; Nicolas H; Nordmann Y
J Clin Invest; 1986 Feb; 77(2):431-5. PubMed ID: 3753711
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of the 281 (Gly----Glu) mutation in hepatoerythropoietic porphyria and porphyria cutanea tarda.
de Verneuil H; Hansen J; Picat C; Grandchamp B; Kushner J; Roberts A; Elder G; Nordmann Y
Hum Genet; 1988 Jan; 78(1):101-2. PubMed ID: 2892774
[TBL] [Abstract][Full Text] [Related]
15. Dual porphyria in double heterozygotes with porphobilinogen deaminase and uroporphyrinogen decarboxylase deficiencies.
Doss MO
Clin Genet; 1989 Feb; 35(2):146-51. PubMed ID: 2721023
[TBL] [Abstract][Full Text] [Related]
16. Familial porphyria cutanea tarda with normal erythrocytic urodecarboxylase: an exception to the rule?
D'Alessandro Gandolfo L; Griso D; Macri A; Biolcati G; Topi GC
Dermatologica; 1989; 178(4):206-8. PubMed ID: 2767288
[TBL] [Abstract][Full Text] [Related]
17. Erythrocyte uroporphyrinogen decarboxylase activity in porphyria cutanea tarda: a study of 40 consecutive patients.
Held JL; Sassa S; Kappas A; Harber LC
J Invest Dermatol; 1989 Sep; 93(3):332-4. PubMed ID: 2768832
[TBL] [Abstract][Full Text] [Related]
18. Reduced substrate affinity for human erythrocyte uroporphyrinogen decarboxylase constitutes the inherent biochemical defect in porphyria cutanea tarda.
Mukerji SK; Pimstone NR
Biochem Biophys Res Commun; 1985 Mar; 127(2):517-25. PubMed ID: 3977935
[TBL] [Abstract][Full Text] [Related]
19. Identification of two types of porphyria cutanea tarda by measurement of erythrocyte uroporphyrinogen decarboxylase.
Elder GH; Sheppard DM; De Salamanca RE; Olmos A
Clin Sci (Lond); 1980 Jun; 58(6):477-84. PubMed ID: 7428280
[TBL] [Abstract][Full Text] [Related]
20. Familial porphyria cutanea tarda: characterization of seven novel uroporphyrinogen decarboxylase mutations and frequency of common hemochromatosis alleles.
Mendez M; Sorkin L; Rossetti MV; Astrin KH; del C Batlle AM; Parera VE; Aizencang G; Desnick RJ
Am J Hum Genet; 1998 Nov; 63(5):1363-75. PubMed ID: 9792863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
